Search
Search titles only
By:
Search titles only
By:
Home
Forums
New posts
Search forums
What's new
New posts
New profile posts
Latest activity
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
Search
Search titles only
By:
Search titles only
By:
New posts
Search forums
Menu
Install the app
Install
Reply to Thread
Guest, we'd love to know what you think about the forum! Take the
Diabetes Forum Survey 2024 »
Home
Forums
Diabetes Discussion
Diabetes Soapbox - Have Your Say
GLP-1s And Gallbladder Disease
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="Oldvatr" data-source="post: 2636982" data-attributes="member: 196898"><p>Here is a similar study done for Tirzeptide, which is an even newer kid on the block but doing the same thing</p><p>[URL unfurl="true"]https://academic.oup.com/jes/article/7/4/bvad016/7005432[/URL]</p><p></p><p>Note AE in this study stands for Adverse Event which includes gastro intestinal discomfort and nausea.</p><p></p><p>it claims gall bladder issues are rare, but the study itself is small (6836) and not necessarily reflecting the general public. So I would say they are being hopeful or looking in the crystal ball. also with several different doses, then the test sample size is at least halved so claiming for all doses being rare is on thin ground IMO. The duration of the trials is not declared and again this weakens their claim. I am of the opinion that they jumped too early and that more research is required to validate these claims.</p><p></p><p>And another referring to Tirzepatide</p><p>[URL unfurl="true"]https://www.ncbi.nlm.nih.gov/books/NBK581694/[/URL]</p><p></p><p>Note Tirzepatide is not yet approved by the FDA and is not yet on general release. It is a mix of Semaglutide and another drug for weight loss.</p></blockquote><p></p>
[QUOTE="Oldvatr, post: 2636982, member: 196898"] Here is a similar study done for Tirzeptide, which is an even newer kid on the block but doing the same thing [URL unfurl="true"]https://academic.oup.com/jes/article/7/4/bvad016/7005432[/URL] Note AE in this study stands for Adverse Event which includes gastro intestinal discomfort and nausea. it claims gall bladder issues are rare, but the study itself is small (6836) and not necessarily reflecting the general public. So I would say they are being hopeful or looking in the crystal ball. also with several different doses, then the test sample size is at least halved so claiming for all doses being rare is on thin ground IMO. The duration of the trials is not declared and again this weakens their claim. I am of the opinion that they jumped too early and that more research is required to validate these claims. And another referring to Tirzepatide [URL unfurl="true"]https://www.ncbi.nlm.nih.gov/books/NBK581694/[/URL] Note Tirzepatide is not yet approved by the FDA and is not yet on general release. It is a mix of Semaglutide and another drug for weight loss. [/QUOTE]
Verification
Post Reply
Home
Forums
Diabetes Discussion
Diabetes Soapbox - Have Your Say
GLP-1s And Gallbladder Disease
Top
Bottom
Find support, ask questions and share your experiences. Ad free.
Join the community »
This site uses cookies. By continuing to use this site, you are agreeing to our use of cookies.
Accept
Learn More.…